缩写名/全名 |
PPAR RES
PPAR Research |
||||||||||||||||||||
ISSN号 | 1687-4757 | ||||||||||||||||||||
研究方向 | MEDICINE, RESEARCH & EXPERIMENTAL- | ||||||||||||||||||||
影响因子 | 2015:2.935, 2016:2.811, 2017:3.386, 2018:4.186, 2019:2.953, | ||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||
出版周期 | |||||||||||||||||||||
年文章数 | 9 | ||||||||||||||||||||
出版年份 | 2006 | ||||||||||||||||||||
是否OA | Yes | ||||||||||||||||||||
审稿周期(仅供参考) | 平均12月 |
||||||||||||||||||||
录用比例 | 约25% | ||||||||||||||||||||
投稿链接 | http://mts.hindawi.com/login/ | ||||||||||||||||||||
投稿官网 | http://www.hindawi.com/journals/ppar/ | ||||||||||||||||||||
h-index | 40 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1687-4757%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Differential Roles of Peroxisome Proliferator-Activated Receptor-α and Receptor-γ on Renal Crystal Formation in Hyperoxaluric Rodents. Author: Taguchi K, Okada A, Hamamoto S, Unno R, Kobayashi T, Ando R, Tozawa K, Gao B, Kohri K, Yasui T. Journal: PPAR Res. 2016;2016:9605890. doi: 10.1155/2016/9605890. Epub 2016 Feb 28. PubMed |
2. | PPARα Agonist Fenofibrate Reduced the Secreting Load of β-Cells in Hypertriglyceridemia Patients with Normal Glucose Tolerance. Author: Liu J, Lu R, Wang Y, Hu Y, Jia Y, Yang N, Fu J, Wang G. Journal: PPAR Res. 2016;2016:6232036. doi: 10.1155/2016/6232036. Epub 2016 Feb 29. PubMed |
3. | Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways. Author: Wei WY, Ma ZG, Xu SC, Zhang N, Tang QZ. Journal: PPAR Res. 2016;2016:9174190. doi: 10.1155/2016/9174190. Epub 2016 Mar 27. PubMed |
4. | PPARgene: A Database of Experimentally Verified and Computationally Predicted PPAR Target Genes. Author: Fang L, Zhang M, Li Y, Liu Y, Cui Q, Wang N. Journal: PPAR Res. 2016;2016:6042162. doi: 10.1155/2016/6042162. Epub 2016 Apr 11. PubMed |
5. | Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis. Author: Liu HJ, Liao HH, Yang Z, Tang QZ. Journal: PPAR Res. 2016;2016:2198645. doi: 10.1155/2016/2198645. Epub 2016 May 12. Review. PubMed |
6. | Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR. Author: Wang Z, Zhang T, Sun L, Li R, Wei Y, Fan X, Yuan Z, Liu J, Chen T. Journal: PPAR Res. 2016;2016:7407153. doi: 10.1155/2016/7407153. Epub 2016 Jun 14. PubMed |
7. | Testosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARα. Author: Yang J, Wang F, Sun W, Dong Y, Li M, Fu L. Journal: PPAR Res. 2016;2016:4518754. doi: 10.1155/2016/4518754. Epub 2016 Jun 16. PubMed |
8. | Protective Effects of Peroxisome Proliferator-Activated Receptor-α Agonist, Wy14643, on Hypoxia/Reoxygenation Injury in Primary Rat Hepatocytes. Author: Chen K, Li YH, Xu SQ, Hu SH, Zhang L. Journal: PPAR Res. 2012;2012:547980. doi: 10.1155/2012/547980. Epub 2011 Oct 9. PubMed |
9. | Fenofibrate enhances the in vitro differentiation of foxp3(+) regulatory T cells in mice. Author: Zhou Z, Liang Y, Gao Y, Kong W, Feng J, Wang X. Journal: PPAR Res. 2012;2012:529035. doi: 10.1155/2012/529035. Epub 2012 Mar 11. PubMed |
10. | Pioglitazone attenuates vascular fibrosis in spontaneously hypertensive rats. Author: Gao D, Ning N, Hao G, Niu X. Journal: PPAR Res. 2012;2012:856426. doi: 10.1155/2012/856426. Epub 2012 Apr 1. PubMed |
|
|